Takeda Pharmaceutical Co Ltd: Form 20-F for the period ended Mar 31, 2025
Filed with the SEC on Jun 25, 2025 and accepted by EDGAR at Jun 25, 2025, 06:23 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-04-01 to 2025-03-31 | JPY 4.58tn | ifrs-full:Revenue |
| Cost of revenue | 12 months2024-04-01 to 2025-03-31 | JPY 1.58tn | ifrs-full:CostOfSales |
| Operating income | 12 months2024-04-01 to 2025-03-31 | JPY 342.59bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2024-04-01 to 2025-03-31 | JPY 66.94bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2024-04-01 to 2025-03-31 | JPY 107.93bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2024-04-01 to 2025-03-31 | JPY 67.23 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2024-04-01 to 2025-03-31 | JPY 68.36 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2024-04-01 to 2025-03-31 | JPY 1.06tn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2024-04-01 to 2025-03-31 | JPY 200.79bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2025-03-31 | JPY 385.11bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2025-03-31 | JPY 2.52tn | ifrs-full:CurrentAssets |
| Total assets | At period end2025-03-31 | JPY 14.25tn | ifrs-full:Assets |
| Current liabilities | At period end2025-03-31 | JPY 2.51tn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2025-03-31 | JPY 7.31tn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2025-03-31 | JPY 6.94tn | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001395064-25-000095. Last ingested by Listed: Nov 5, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.